Titan Pharma receives fda communication on ropinirole implant Investigational new drug application

Titan Pharmaceuticals, Inc, a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura long-term, continuous drug delivery platform announced that the U.S. FDA has completed its initial review...

Novartis Zykadia receives FDA Priority Review for first-line use in patients with ALK metastatic NSCLC

Novartis announced that the US FDA accepted the Companys supplemental New Drug Application (sNDA) for filing, and granted Priority Review for the expanded use of Zykadia.

Obagi Medical collaboration with suzan obagi and nextcell medical to introduce new line of products

Valeant Pharmaceuticals International, Incs wholly owned subsidiary Obagi Medical Products, a long time leader in professional skin care announced a collaboration with Nextcell Medical Company...

Inovio reports new positive clinical data on vaccine advances against emerging Infectious diseases

Inovio Pharmaceuticals, Inc. announced that Dr. David B. Weiner, Inovios co-founder, presented positive clinical data on Inovios DNA-based vaccines against MERS (GLS-5300) and Zika...

Videojet introduces new pink UV fluorescent ink to drive productivity

Fluorescing UV ink is only visible under UV lighting, satisfying the need for a robust but invisible solution, allowing discrete codes and brand information to be tracked through the supply chain.

Recipharm completes strategic acquisition in India

Recipharm AB announces that it has now concluded the acquisition of Kemwells pharmaceutical businesses located in Bengaluru, India.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com